Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03168139 |
|---|---|
| Brief Title: | Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer (Keynote-559) |
| First Submitted : | May 19, 2017 |
| First Submitted that Met QC Criteria : | May 24, 2017 |
| First Posted : | May 30, 2017 |
| Last Update Submitted that Met QC Criteria : | July 7, 2020 |
| Last Update Posted : | July 8, 2020 |